| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |